HIV-1 shedding from the female genital tract is associated with increased Th1 cytokines/chemokines that maintain tissue homeostasis and proportions of CD8+FOXP3+ T cells

Journal of Acquired Immune Deficiency Syndromes

Volumn 67, Issue 4, 2014, Pages 357-364

  Bull, Marta E ^a,b   Legard, Jillian ^b,f   Tapia, Kenneth ^c   Sorensen, Bess ^c,g   Cohn, Susan E ^d,h   Garcia, Rochelle ^c   Holte, Sarah E ^c,e   Coombs, Robert W ^c   Hitti, Jane E ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

^f SEATTLE CHILDREN S HOSPITAL   (United States)

^g Gilead Sciences   (United States)

^h NORTHWESTERN UNIVERSITY   (United States)

Author keywords

CD8+FOXP3+ cells; Cytokines chemokines; Genital shedding; HIV 1; Women

Indexed keywords

FRACTALKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 23; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; RANTES; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; CHEMOKINE; CYTOKINE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DISEASE TRANSMISSION; FEMALE; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; TH1 CELL; UTERINE CERVIX; VIRUS LOAD; VIRUS REPLICATION; VIRUS SHEDDING; CD8+ T LYMPHOCYTE; FEMALE GENITAL SYSTEM; HOMEOSTASIS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION; VIROLOGY;

CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINE CX3CL1; CHEMOKINES; CYTOKINES; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENITALIA, FEMALE; HIV INFECTIONS; HIV-1; HOMEOSTASIS; HUMANS; INTERLEUKIN-7; T-LYMPHOCYTE SUBSETS; TH1 CELLS; VIRAL LOAD; VIRUS SHEDDING;

EID: 84922481832     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000336     Document Type: Article

References (46)

1. Lawn SD, Subbarao S, Wright TC Jr, et al. Correlation between human immunodeficiency virus type 1 RNA levels in the female genital tract and immune activation associated with ulceration of the cervix. J Infect Dis. 2000;181:1950-1956.
2. Jaspan HB, Liebenberg L, Hanekom W, et al. Immune activation in the female genital tract during HIV infection predicts mucosal CD4 depletion and HIV shedding. J Infect Dis. 2011;204:1550-1556.
3. Mitchell C, Hitti J, Paul K, et al. Cervicovaginal shedding of HIV type 1 is related to genital tract inflammation independent of changes in vaginal microbiota. AIDS Res Hum Retroviruses. 2011;27:35-39.
4. Blish CA, McClelland RS, Richardson BA, et al. Genital inflammation predicts HIV-1 shedding independent of plasma viral load and systemic inflammation. J Acquir Immun Defic Syndr. 2012;61:436-440.
5. Homans J, Christensen S, Stiller T, et al. Permissive and protective factors associated with presence, level, and longitudinal pattern of cervicovaginal HIV shedding. J Acquir Immun Defic Syndr. 2012;60:99-110.
6. Herold BC, Keller MJ, Shi Q, et al. Plasma and mucosal HIV viral loads are associated with genital tract inflammation in HIV-infected women. J Acquir Immun Defic Syndr. 2013;63:485-493.
7. Tanton C, Weiss HA, Le Goff J, et al. Correlates of HIV-1 genital shedding in Tanzanian women. PLoS One. 2011;6:e17480.
8. Reichelderfer PS, Coombs RW, Wright DJ, et al. Effect of menstrual cycle on HIV-1 levels in the peripheral blood and genital tract. WHS 001 Study Team. AIDS. 2000;14:2101-2107.
9. Curlin ME, Leelawiwat W, Dunne EF, et al. Cyclic changes in HIV shedding from the female genital tract during the menstrual cycle. J Infect Dis. 2013;207:1616-1620.
10. Cohen CR, Lingappa JR, Baeten JM, et al. Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples. PLoS Med. 2012;9:e1001251.
11. Mane A, Kulkarni S, Ghate M, et al. HIV-1 RNA shedding in the female genital tract is associated with reduced quantity of Lactobacilli in clinically asymptomatic HIV-positive women. Diagn Microbiol Infect Dis. 2013;75:112-114.
12. Mitchell C, Balkus JE, Fredricks D, et al. Interaction between lactobacilli, bacterial vaginosis-associated bacteria, and HIV type 1 RNA and DNA genital shedding in U.S. and Kenyan women. AIDS Res Hum Retroviruses. 2013;29:13-19.
13. Adurthi S, Mukherjee G, Krishnamurthy H, et al. Functional tumor infiltrating TH1 and TH2 effectors in large early-stage cervical cancer are suppressed by regulatory T cells. Int J Gynecol Cancer. 2012;22: 1130-1137.
14. El Hed A, Khaitan A, Kozhaya L, et al. Susceptibility of human Th17 cells to human immunodeficiency virus and their perturbation during infection. J Infect Dis. 2010;201:843-854.
15. McKinnon LR, Nyanga B, Chege D, et al. Characterization of a human cervical CD4+ T cell subset coexpressing multiple markers of HIV susceptibility. J Immunol. 2011;187:6032-6042.
16. Mitchell CM, Balkus J, Agnew KJ, et al. Bacterial vaginosis, not HIV, is primarily responsible for increased vaginal concentrations of proinflammatory cytokines. AIDS Res Hum Retroviruses. 2008;24:667-671.
17. Bull ME, Learn GH, McElhone S, et al. Monotypic human immunodeficiency virus type 1 genotypes across the uterine cervix and in blood suggest proliferation of cells with provirus. J Virol. 2009;83:6020-6028.
18. Favre D, Lederer S, Kanwar B, et al. Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLoS Pathog. 2009;5:e1000295.
19. Fraticelli P, Sironi M, Bianchi G, et al. Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J Clin Invest. 2001; 107:1173-1181.
20. Rabin RL, Alston MA, Sircus JC, et al. CXCR3 is induced early on the pathway of CD4+ T cell differentiation and bridges central and peripheral functions. J Immunol. 2003;171:2812-2824.
21. Wright TC Jr, Subbarao S, Ellerbrock TV, et al. Human immunodeficiency virus 1 expression in the female genital tract in association with cervical inflammation and ulceration. Am J Obstet Gynecol. 2001;184: 279-285.
22. Iversen AK, Larsen AR, Jensen T, et al. Distinct determinants of human immunodeficiency virus type 1 RNA and DNA loads in vaginal and cervical secretions. J Infect Dis. 1998;177:1214-1220.
23. Shearer WT. HIV infection and AIDS. Prim Care. 1998;25:759-774.
24. Levy Y, Sereti I, Tambussi G, et al. Effects of recombinant human interleukin 7 on T-cell recovery and thymic output in HIV-infected patients receiving antiretroviral therapy: results of a phase I/IIa randomized, placebo-controlled, multicenter study. Clin Infect Dis. 2012; 55:291-300.
25. Chevalier MF, Weiss L. The split personality of regulatory T cells in HIV infection. Blood. 2013;121:29-37.
26. Chen JJ, Huang JC, Shirtliff M, et al. CD4 lymphocytes in the blood of HIV(+) individuals migrate rapidly to lymph nodes and bone marrow: support for homing theory of CD4 cell depletion. J Leukoc Biol. 2002;72: 271-278.
27. Andersson J, Boasso A, Nilsson J, et al. The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. J Immunol. 2005;174:3143-3147.
28. Kinter A, McNally J, Riggin L, et al. Suppression of HIV-specific T cell activity by lymph node CD25+ regulatory T cells from HIV-infected individuals. Proc Natl Acad Sci U S A. 2007;104:3390-3395.
29. Al-Harthi L, Kovacs A, Coombs RW, et al. A menstrual cycle pattern for cytokine levels exists in HIV-positive women: implication for HIV vaginal and plasma shedding. AIDS. 2001;15:1535-1543.
30. Iversen AK, Attermann J, Gerstoft J, et al. Longitudinal and crosssectional studies of HIV-1 RNA and DNA loads in blood and the female genital tract. Eur J Obstet Gynecol Reprod Biol. 2004;117: 227-235.
31. Rebbapragada A, Howe K, Wachihi C, et al. Bacterial vaginosis in HIVinfected women induces reversible alterations in the cervical immune environment. J Acquir Immun Defic Syndr. 2008;49:520-522.
32. Blish CA, Dogan OC, Jaoko W, et al. Cellular immune responses and susceptibility to HIV-1 superinfection: a case-control study. AIDS. 2012; 26:643-646.
33. Mukura LR, Ghosh M, Fahey JV, et al. Genital tract viral load in HIV Type 1-positive women correlates with specific cytokine levels in cervical-vaginal secretions but is not a determinant of infectious virus or anti-HIV activity. AIDS Res Hum Retroviruses. 2012;28:1533-1539.
34. Boyman O, Purton JF, Surh CD, et al. Cytokines and T-cell homeostasis. Curr Opin Immunol. 2007;19:320-326.
35. Zara F, Nappi RE, Brerra R, et al. Markers of local immunity in cervicovaginal secretions of HIV infected women: implications for HIV shedding. Sex Transm Infect. 2004;80:108-112.
36. Cummins JE, Christensen L, Lennox JL, et al. Mucosal innate immune factors in the female genital tract are associated with vaginal HIV-1 shedding independent of plasma viral load. AIDS Res Hum Retroviruses. 2006;22:788-795.
37. Suthanthiran M, Li B, Song JO, et al. Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: a novel mediator of hypertension and/or target organ damage. Proc Natl Acad Sci U S A. 2000;97:3479-3484.
38. Fantasia J, Lin CB, Wiwi C, et al. Differential levels of elastin fibers and TGF-beta signaling in the skin of Caucasians and African Americans. J Dermatol Sci. 2013;70:159-165.
39. Lee SB, Kanasaki K, Kalluri R. Circulating TGF-beta1 as a reliable biomarker for chronic kidney disease progression in the African-American population. Kidney Int. 2009;76:10-12.
40. Crowley-Nowick PA, Ellenberg JH, Vermund SH, et al. Cytokine profile in genital tract secretions from female adolescents: impact of human immunodeficiency virus, human papillomavirus, and other sexually transmitted pathogens. J Infect Dis. 2000;181:939-945.
41. Spear GT, Zariffard MR, Chen HY, et al. Positive association between HIV RNA and IL-6 in the genital tract of Rwandan women. AIDS Res Hum Retroviruses. 2008;24:973-976.
42. George J, Cofano EB, Lybarger E, et al. Early short-term antiretroviral therapy is associated with a reduced prevalence of CD8(+)FoxP3(+) T cells in simian immunodeficiency virus-infected controller rhesus macaques. AIDS Res Hum Retroviruses. 2011;27:763-775.
43. Suzuki M, Jagger AL, Konya C, et al. CD8+CD45RA+CCR7 +FOXP3+ T cells with immunosuppressive properties: a novel subset of inducible human regulatory T cells. J Immunol. 2012;189: 2118-2130.
44. Hirbod T, Kimani J, Tjernlund A, et al. Stable CD4 expression and local immune activation in the ectocervical mucosa of HIV-infected women. J Immunol. 2013;191:3948-3954.
45. Gibbs A, Hirbod T, Li Q, et al. Presence of CD8+ T cells in the ectocervical mucosa correlates with genital viral shedding in HIV-infected women despite a low prevalence of HIV RNA-expressing cells in the tissue. J Immunol. 2014;192:3947-3957.
46. Chaput N, Louafi S, Bardier A, et al. Identification of CD8+CD25 +Foxp3+ suppressive T cells in colorectal cancer tissue. Gut. 2009; 58:520-529.